The small RNA miR-375 – a pancreatic islet abundant miRNA with multiple roles in endocrine beta cell function

Molecular and Cellular Endocrinology

Volumn 456, Issue , 2017, Pages 95-101

  Eliasson, Lena ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Beta cell; Diabetes; Differentiation; Insulin; Insulin secretion; Islet of langerhans; MicroRNA; miR 375; Proliferation

Indexed keywords

BIOLOGICAL MARKER; MICRORNA 375; INSULIN; MICRORNA; MIRN375 MICRORNA, HUMAN;

ARTICLE; BIOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; EXOCYTOSIS; GENE EXPRESSION REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT MODEL; UPREGULATION; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; PATHOLOGY; RAT; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL DIFFERENTIATION; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICRORNAS; RATS; SIGNAL TRANSDUCTION;

EID: 85014520847     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2017.02.043     Document Type: Article

References (61)

1. Ashcroft, F.M., Rorsman, P., Diabetes mellitus and the beta cell: the last ten years. Cell 148 (2012), 1160–1171.
2. Avnit-Sagi, T., Kantorovich, L., Kredo-Russo, S., Hornstein, E., Walker, M.D., The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One, 4, 2009, e5033.
3. Bacos, K., Gillberg, L., Volkov, P., Olsson, A.H., Hansen, T., Pedersen, O., Gjesing, A.P., Eiberg, H., Tuomi, T., Almgren, P., Groop, L., Eliasson, L., Vaag, A., Dayeh, T., Ling, C., Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes. Nat. Commun., 7, 2016, 11089.
4. Baroukh, N.N., Van Obberghen, E., Function of microRNA-375 and microRNA-124a in pancreas and brain. FEBS J. 276 (2009), 6509–6521.
5. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
6. Beermann, J., Piccoli, M.T., Viereck, J., Thum, T., Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol. Rev. 96 (2016), 1297–1325.
7. Bolmeson, C., Esguerra, J.L., Salehi, A., Speidel, D., Eliasson, L., Cilio, C.M., Differences in islet-enriched miRNAs in healthy and glucose intolerant human subjects. Biochem. Biophys. Res. Commun. 404 (2011), 16–22.
8. Braun, M., Ramracheya, R., Bengtsson, M., Zhang, Q., Karanauskaite, J., Partridge, C., Johnson, P.R., Rorsman, P., Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57 (2008), 1618–1628.
9. Bravo-Egana, V., Rosero, S., Molano, R.D., Pileggi, A., Ricordi, C., Dominguez-Bendala, J., Pastori, R.L., Quantitative differential expression analysis reveals miR-7 as major islet microRNA. Biochem. Biophys. Res. Commun. 366 (2008), 922–926.
10. Brereton, M.F., Rohm, M., Ashcroft, F.M., beta-Cell dysfunction in diabetes: a crisis of identity?. Diabetes Obes. Metab. 18:Suppl. 1 (2016), 102–109.
11. Carreras-Badosa, G., Bonmati, A., Ortega, F.J., Mercader, J.M., Guindo-Martinez, M., Torrents, D., Prats-Puig, A., Martinez-Calcerrada, J.M., Platero-Gutierrez, E., De Zegher, F., Ibanez, L., Fernandez-Real, J.M., Lopez-Bermejo, A., Bassols, J., Altered circulating miRNA expression profile in pregestational and gestational obesity. J. Clin. Endocrinol. Metab. 100 (2015), E1446–E1456.
12. Chakrabarti, S.K., Mirmira, R.G., Transcription factors direct the development and function of pancreatic beta cells. Trends Endocrinol. Metab. 14 (2003), 78–84.
13. Delic, D., Eisele, C., Schmid, R., Luippold, G., Mayoux, E., Grempler, R., Characterization of micro-RNA changes during the progression of type 2 diabetes in zucker diabetic fatty rats. Int. J. Mol. Sci., 17, 2016.
14. Dumortier, O., Hinault, C., Gautier, N., Patouraux, S., Casamento, V., Van Obberghen, E., Maternal protein restriction leads to pancreatic failure in offspring: role of misexpressed microRNA-375. Diabetes 63 (2014), 3416–3427.
15. El Ouaamari, A., Baroukh, N., Martens, G.A., Lebrun, P., Pipeleers, D., van Obberghen, E., miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57 (2008), 2708–2717.
16. Eliasson, L., Esguerra, J.L., Role of non-coding RNAs in pancreatic beta-cell development and physiology. Acta Physiol. (Oxf) 211 (2014), 273–284.
17. Erener, S., Mojibian, M., Fox, J.K., Denroche, H.C., Kieffer, T.J., Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice. Endocrinology 154 (2013), 603–608.
18. Esguerra, J.L., Bolmeson, C., Cilio, C.M., Eliasson, L., Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS One, 6, 2011, e18613.
19. Esguerra, J.L., Mollet, I.G., Salunkhe, V.A., Wendt, A., Eliasson, L., Regulation of pancreatic beta cell stimulus-secretion coupling by microRNAs. Genes (Basel) 5 (2014), 1018–1031.
20. Fabian, M.R., Sonenberg, N., The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19 (2012), 586–593.
21. Farh, K.K., Grimson, A., Jan, C., Lewis, B.P., Johnston, W.K., Lim, L.P., Burge, C.B., Bartel, D.P., The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310 (2005), 1817–1821.
22. Flowers, E., Aouizerat, B.E., Abbasi, F., Lamendola, C., Grove, K.M., Fukuoka, Y., Reaven, G.M., Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: moving towards precision health for diabetes prevention. Metabolism 64 (2015), 1051–1059.
23. Goto, Y., Kakizaki, M., Masaki, N., Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J. Exp. Med. 119 (1976), 85–90.
24. Guay, C., Regazzi, R., Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat. Rev. Endocrinol. 9 (2013), 513–521.
25. Halban, P.A., Polonsky, K.S., Bowden, D.W., Hawkins, M.A., Ling, C., Mather, K.J., Powers, A.C., Rhodes, C.J., Sussel, L., Weir, G.C., beta-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment. Diabetes Care 37 (2014), 1751–1758.
26. Higuchi, C., Nakatsuka, A., Eguchi, J., Teshigawara, S., Kanzaki, M., Katayama, A., Yamaguchi, S., Takahashi, N., Murakami, K., Ogawa, D., Sasaki, S., Makino, H., Wada, J., Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes. Metabolism 64 (2015), 489–497.
27. Jafarian, A., Taghikani, M., Abroun, S., Allahverdi, A., Lamei, M., Lakpour, N., Soleimani, M., The generation of insulin producing cells from human mesenchymal stem cells by MiR-375 and anti-MiR-9. PLoS One, 10, 2015, e0128650.
28. Joglekar, M.V., Joglekar, V.M., Hardikar, A.A., Expression of islet-specific microRNAs during human pancreatic development. Gene Expr. Patterns 9 (2009), 109–113.
29. Kalis, M., Bolmeson, C., Esguerra, J.L., Gupta, S., Edlund, A., Tormo-Badia, N., Speidel, D., Holmberg, D., Mayans, S., Khoo, N.K., Wendt, A., Eliasson, L., Cilio, C.M., Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus. PLoS One, 6, 2011, e29166.
30. Keller, D.M., McWeeney, S., Arsenlis, A., Drouin, J., Wright, C.V., Wang, H., Wollheim, C.B., White, P., Kaestner, K.H., Goodman, R.H., Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J. Biol. Chem. 282 (2007), 32084–32092.
31. Keller, D.M., Clark, E.A., Goodman, R.H., Regulation of microRNA-375 by cAMP in pancreatic beta-cells. Mol. Endocrinol. 26 (2012), 989–999.
32. Kong, L., Zhu, J., Han, W., Jiang, X., Xu, M., Zhao, Y., Dong, Q., Pang, Z., Guan, Q., Gao, L., Zhao, J., Zhao, L., Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 48 (2011), 61–69.
33. Latreille, M., Herrmanns, K., Renwick, N., Tuschl, T., Malecki, M.T., McCarthy, M.I., Owen, K.R., Rulicke, T., Stoffel, M., miR-375 gene dosage in pancreatic beta-cells: implications for regulation of beta-cell mass and biomarker development. J. Mol. Med. Berl. 93 (2015), 1159–1169.
34. Lynn, F.C., Skewes-Cox, P., Kosaka, Y., McManus, M.T., Harfe, B.D., German, M.S., MicroRNA expression is required for pancreatic islet cell genesis in the mouse. Diabetes 56 (2007), 2938–2945.
35. Malm, H.A., Mollet, I.G., Berggreen, C., Orho-Melander, M., Esguerra, J.L., Goransson, O., Eliasson, L., Transcriptional regulation of the miR-212/miR-132 cluster in insulin-secreting beta-cells by cAMP-regulated transcriptional co-activator 1 and salt-inducible kinases. Mol. Cell Endocrinol. 424 (2016), 23–33.
36. Martinez-Sanchez, A., Nguyen-Tu, M.S., Rutter, G.A., DICER inactivation identifies pancreatic beta-cell “disallowed” genes targeted by MicroRNAs. Mol. Endocrinol. 29 (2015), 1067–1079.
37. Mathis, D., Vence, L., Benoist, C., beta-Cell death during progression to diabetes. Nature 414 (2001), 792–798.
38. McKinnon, C.M., Docherty, K., Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44 (2001), 1203–1214.
39. Melkman-Zehavi, T., Oren, R., Kredo-Russo, S., Shapira, T., Mandelbaum, A.D., Rivkin, N., Nir, T., Lennox, K.A., Behlke, M.A., Dor, Y., Hornstein, E., miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J. 30 (2011), 835–845.
40. Mollet, I.G., Malm, H.A., Wendt, A., Orho-Melander, M., Eliasson, L., Integrator of stress responses calmodulin binding transcription activator 1 (Camta1) regulates miR-212/miR-132 expression and insulin secretion. J. Biol. Chem. 291 (2016), 18440–18452.
41. Nathan, G., Kredo-Russo, S., Geiger, T., Lenz, A., Kaspi, H., Hornstein, E., Efrat, S., MiR-375 promotes redifferentiation of adult human beta cells expanded in vitro. PLoS One, 10, 2015, e0122108.
42. Portha, B., Lacraz, G., Kergoat, M., Homo-Delarche, F., Giroix, M.H., Bailbe, D., Gangnerau, M.N., Dolz, M., Tourrel-Cuzin, C., Movassat, J., The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?. Mol. Cell Endocrinol. 297 (2009), 73–85.
43. Poy, M.N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P.E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., Stoffel, M., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432 (2004), 226–230.
44. Poy, M.N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., Stoffel, M., miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 5813–5818.
45. Pullen, T.J., da Silva Xavier, G., Kelsey, G., Rutter, G.A., miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol. Cell Biol. 31 (2011), 3182–3194.
46. Qiu, Y., Guo, M., Huang, S., Stein, R., Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol. Cell Biol. 22 (2002), 412–420.
47. Salunkhe, V.A., Esguerra, J.L., Ofori, J.K., Mollet, I.G., Braun, M., Stoffel, M., Wendt, A., Eliasson, L., Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells. Acta Physiol. (Oxf) 213 (2015), 882–892.
48. Samandari, N., Mirza, A.H., Nielsen, L.B., Kaur, S., Hougaard, P., Fredheim, S., Mortensen, H.B., Pociot, F., Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus. Diabetologia 60 (2017), 354–363.
49. Sebastiani, G., Po, A., Miele, E., Ventriglia, G., Ceccarelli, E., Bugliani, M., Marselli, L., Marchetti, P., Gulino, A., Ferretti, E., Dotta, F., MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta Diabetol. 52 (2015), 523–530.
50. Seyhan, A.A., Nunez Lopez, Y.O., Xie, H., Yi, F., Mathews, C., Pasarica, M., Pratley, R.E., Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci. Rep., 6, 2016, 31479.
51. Shang, J., Li, J., Keller, M.P., Hohmeier, H.E., Wang, Y., Feng, Y., Zhou, H.H., Shen, X., Rabaglia, M., Soni, M., Attie, A.D., Newgard, C.B., Thornberry, N.A., Howard, A.D., Zhou, Y.P., Induction of miR-132 and miR-212 expression by glucagon-like peptide 1 (GLP-1) in rodent and human pancreatic beta-cells. Mol. Endocrinol. 29 (2015), 1243–1253.
52. Sun, K., Chang, X., Yin, L., Li, J., Zhou, T., Zhang, C., Chen, X., Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus. Mol. Med. Rep. 9 (2014), 967–972.
53. Tattikota, S.G., Rathjen, T., McAnulty, S.J., Wessels, H.H., Akerman, I., van de Bunt, M., Hausser, J., Esguerra, J.L., Musahl, A., Pandey, A.K., You, X., Chen, W., Herrera, P.L., Johnson, P.R., O'Carroll, D., Eliasson, L., Zavolan, M., Gloyn, A.L., Ferrer, J., Shalom-Feuerstein, R., Aberdam, D., Poy, M.N., Argonaute2 mediates compensatory expansion of the pancreatic beta cell. Cell Metab. 19 (2014), 122–134.
54. Tattikota, S.G., Rathjen, T., Hausser, J., Khedkar, A., Kabra, U.D., Pandey, V., Sury, M., Wessels, H.H., Mollet, I.G., Eliasson, L., Selbach, M., Zinzen, R.P., Zavolan, M., Kadener, S., Tschop, M.H., Jastroch, M., Friedlander, M.R., Poy, M.N., miR-184 regulates pancreatic beta-cell function according to glucose metabolism. J. Biol. Chem. 290 (2015), 20284–20294.
55. van de Bunt, M., Gaulton, K.J., Parts, L., Moran, I., Johnson, P.R., Lindgren, C.M., Ferrer, J., Gloyn, A.L., McCarthy, M.I., The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis. PLoS One, 8, 2013, e55272.
56. Wei, R., Yang, J., Liu, G.Q., Gao, M.J., Hou, W.F., Zhang, L., Gao, H.W., Liu, Y., Chen, G.A., Hong, T.P., Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells. Gene 518 (2013), 246–255.
57. Winter, J., Jung, S., Keller, S., Gregory, R.I., Diederichs, S., Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11 (2009), 228–234.
58. Yamada, H., Itoh, M., Hiratsuka, I., Hashimoto, S., Circulating microRNAs in autoimmune thyroid diseases. Clin. Endocrinol. (Oxf) 81 (2014), 276–281.
59. Yang, B.T., Dayeh, T.A., Volkov, P.A., Kirkpatrick, C.L., Malmgren, S., Jing, X., Renstrom, E., Wollheim, C.B., Nitert, M.D., Ling, C., Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol. 26 (2012), 1203–1212.
60. Zhao, L., Guo, M., Matsuoka, T.A., Hagman, D.K., Parazzoli, S.D., Poitout, V., Stein, R., The islet beta cell-enriched MafA activator is a key regulator of insulin gene transcription. J. Biol. Chem. 280 (2005), 11887–11894.
61. Zhou, Y.P., Marlen, K., Palma, J.F., Schweitzer, A., Reilly, L., Gregoire, F.M., Xu, G.G., Blume, J.E., Johnson, J.D., Overexpression of repressive cAMP response element modulators in high glucose and fatty acid-treated rat islets. A common mechanism for glucose toxicity and lipotoxicity?. J. Biol. Chem. 278 (2003), 51316–51323.